Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN000616 | 54.02 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 57.07 | 7.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 61.04 | 0.7 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 74.03 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 74.53 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 76.08 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 76.08 | 1.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 77.04 | 2.44 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 79.02 | 0.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 80.01 | 0.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 80.95 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 81.02 | 0.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 81.07 | 7.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 82.54 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 82.95 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 83 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 83.02 | 0.62 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 83.05 | 1.83 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 83.09 | 3.99 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 83.09 | 7.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 85 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 86.06 | 0.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 86.1 | 0.85 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 96.92 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 97.99 | 1.81 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 98.06 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 98.06 | 12.46 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 98.92 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 98.99 | 0.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 100.52 | 1.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 101 | 0.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 101.06 | 1.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 103.13 | 0.72 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 104.07 | 0.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 104.11 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 105.03 | 2.44 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 106.04 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 107.05 | 2.22 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 107.05 | 3.11 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 109.06 | 3.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 110.03 | 0.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 110.06 | 0.62 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 112.04 | 0.79 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 112.9 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 113.99 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 114.03 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 114.13 | 6.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 114.89 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 115.07 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 115.07 | 1.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 116.11 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 118.06 | 0.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 120.04 | 1.73 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 120.08 | 1.05 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 120.97 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 121.03 | 1.15 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 121.07 | 0.7 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 122.06 | 1.21 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 122.08 | 0.71 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 122.09 | 0.79 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 123.05 | 1.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 124.02 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 124.08 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 125.02 | 1.16 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 125.54 | 4.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 126.02 | 0.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 127.04 | 0.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 127.04 | 1.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 127.05 | 3.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 127.54 | 4.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 128.11 | 3.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 129.06 | 0.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 129.06 | 1.16 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 129.06 | 1.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 130.02 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 130.05 | 0.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 130.05 | 2.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 130.05 | 5.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 130.06 | 4.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 130.08 | 0.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 131.05 | 4.49 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 131.12 | 0.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 132.04 | 1.81 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 132.08 | 0.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 132.1 | 0.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 133.07 | 0.73 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 133.1 | 0.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 134.55 | 4.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 135.12 | 5.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 136.05 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 136.94 | 0.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 137.05 | 0.69 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 137.06 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 137.06 | 3.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 138.06 | 0.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 138.09 | 0.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 138.91 | 0.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 138.94 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 139.15 | 7.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 140.07 | 0.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 140.9 | 0.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 141.04 | 2.99 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 141.05 | 1.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 141.06 | 0.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 141.06 | 6.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 141.55 | 5.76 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 141.56 | 4.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 142.03 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 142.05 | 3.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 142.05 | 5.35 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 142.08 | 0.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 142.95 | 0.73 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 143.02 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 143.07 | 2.83 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 143.08 | 0.76 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 143.12 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 144.05 | 0.99 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 144.06 | 0.91 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 144.1 | 0.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 144.1 | 5.11 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 144.1 | 5.48 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 145.05 | 0.73 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 145.11 | 0.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 146.06 | 4.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 146.06 | 4.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 146.06 | 5.31 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 146.09 | 0.68 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 147.07 | 1.36 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 147.08 | 0.76 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 147.08 | 2.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 147.11 | 0.56 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 147.55 | 5.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 148 | 0.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 148.04 | 0.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 148.05 | 4.12 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 148.1 | 0.69 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 149.1 | 4 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 150.04 | 3.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 150.05 | 1.27 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 150.54 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 151.04 | 1.5 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 151.06 | 0.89 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 151.09 | 0.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 151.14 | 0.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 152.02 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 152.03 | 0.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 152.06 | 0.89 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 152.54 | 2.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 153.06 | 1.31 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 153.07 | 0.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 153.13 | 5.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 154.02 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 154.06 | 0.68 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 154.06 | 0.79 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 155.01 | 1.19 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 155.01 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 155.01 | 3.33 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 155.01 | 3.76 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 155.01 | 4.05 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 155.05 | 0.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 155.06 | 5.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 155.07 | 3.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 156.04 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 156.08 | 0.79 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 156.09 | 3.62 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 156.14 | 6.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 157.06 | 0.76 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 157.09 | 4 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 158.04 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 158.08 | 1.2 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 158.08 | 1.83 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 158.09 | 0.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 160.01 | 1.4 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 160.04 | 0.62 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 160.05 | 0.62 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 160.1 | 0.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 160.1 | 1.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 160.1 | 2.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 160.11 | 0.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 160.13 | 0.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 160.13 | 6.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 161.02 | 0.54 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 161.06 | 4.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 161.56 | 3.26 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 161.58 | 6.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 162.02 | 3.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 162.05 | 2.44 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 162.05 | 3.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 162.06 | 0.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 162.07 | 0.8 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 162.11 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 162.11 | 0.8 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 162.56 | 3.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 162.95 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 164.07 | 0.85 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 164.07 | 4.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 164.93 | 0.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 165.05 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 166.03 | 1.41 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 166.03 | 4.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 166.07 | 0.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 166.08 | 1.05 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 167.05 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 167.06 | 0.91 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 167.11 | 3.71 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 167.11 | 3.99 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 168.06 | 0.87 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 168.12 | 4 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 168.56 | 4.13 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 169.05 | 1.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 169.05 | 1.16 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 169.06 | 0.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 169.08 | 2.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 169.12 | 4.39 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 170.03 | 0.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 170.05 | 1.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 170.09 | 0.78 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 171.03 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 171.06 | 1.25 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 171.07 | 0.89 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 171.09 | 0.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 171.09 | 2.21 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 171.1 | 4.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 171.11 | 2.23 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 172.1 | 3.78 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 172.55 | 2.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 173.08 | 2.2 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 173.08 | 4.32 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 173.08 | 4.9 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 173.08 | 5.3 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 173.13 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 173.13 | 1.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 174.05 | 5.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 174.11 | 4.09 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 174.12 | 0.81 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 175 | 0.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 175.05 | 0.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 175.08 | 3.03 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 175.11 | 0.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 175.13 | 0.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 175.57 | 5.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 176.01 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 176.07 | 1.16 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 177.2 | 0.72 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 177.96 | 2.21 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 178.06 | 0.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 178.09 | 1.37 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 180.04 | 4.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 180.07 | 2.44 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 180.08 | 0.89 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 180.09 | 1.2 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 180.1 | 1.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 180.9 | 0.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 181.06 | 1.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 181.07 | 2.44 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 182.06 | 0.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 182.07 | 1.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 182.08 | 0.79 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 182.08 | 3.09 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 183.05 | 0.87 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 183.06 | 0.54 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 183.07 | 1.11 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 183.08 | 1.08 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 183.08 | 2.96 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 183.09 | 3.1 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 183.1 | 4.08 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 183.1 | 5.36 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 184.05 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 184.05 | 0.92 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 184.09 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 184.1 | 3.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 184.13 | 6.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 185.01 | 1.5 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 185.03 | 1.48 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 185.04 | 4 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 185.11 | 3.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 185.12 | 3.99 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 185.12 | 4.48 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 185.12 | 5.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 185.13 | 0.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 185.13 | 1.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 185.96 | 0.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 186.04 | 0.52 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 186.1 | 0.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 186.11 | 3.98 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 188.07 | 1.36 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 188.09 | 1.39 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 188.18 | 0.54 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 189.05 | 0.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 189.07 | 1.78 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 189.11 | 4.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 189.14 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 189.16 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 190.05 | 1.51 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 190.05 | 3.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 190.06 | 3.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 191.07 | 4.35 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 192.07 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 192.07 | 0.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 192.07 | 3.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 192.11 | 3.03 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 193.06 | 5.04 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 193.15 | 0.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 194.01 | 0.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 194.03 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 194.08 | 3.22 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 194.08 | 4.04 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 194.11 | 1.98 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 194.56 | 5.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 195 | 0.87 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 195.07 | 1.72 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 195.09 | 2.97 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 195.11 | 1.04 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 195.14 | 5.13 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 195.14 | 6.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 196.04 | 2.44 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 196.04 | 3.35 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 196.06 | 1.2 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 196.06 | 3.36 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 196.09 | 1.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 196.09 | 3.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 196.87 | 0.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 197.06 | 1.28 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 197.08 | 4.03 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 197.12 | 6.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 197.13 | 3.04 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 198.06 | 0.81 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 198.06 | 1.25 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 198.87 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 199.04 | 2.56 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 199.08 | 0.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 199.1 | 3.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 199.1 | 4.48 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 199.11 | 1.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 199.54 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 199.56 | 5.44 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 200.07 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 200.13 | 5.52 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 201.03 | 6.88 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 201.11 | 4.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 201.11 | 5.49 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 202.06 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 202.14 | 6.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 202.52 | 3.46 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 202.97 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 203.04 | 0.54 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 203.04 | 1.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 203.06 | 0.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 203.08 | 0.88 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 203.11 | 5.05 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 203.13 | 4 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 203.15 | 0.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 204.04 | 0.52 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 204.07 | 3.11 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 204.07 | 3.62 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 204.09 | 5.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 204.09 | 7.23 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 204.12 | 0.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 204.12 | 4.08 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 204.97 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 205.05 | 3.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 205.07 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 205.1 | 1.37 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 206.08 | 3.78 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 206.08 | 4.49 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 206.1 | 1.76 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 206.59 | 7.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 207.1 | 5.1 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 207.14 | 3.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 207.17 | 0.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 208.05 | 0.8 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 208.06 | 0.79 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 208.09 | 4.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 208.1 | 4.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 208.11 | 1.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 209.09 | 1.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 209.12 | 4.99 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 209.13 | 3.92 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 209.15 | 4.89 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 210.06 | 4.36 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 210.08 | 3.37 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 210.16 | 0.54 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 211.07 | 0.9 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 211.1 | 4.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 211.12 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 211.13 | 4.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 211.14 | 4.11 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 212.1 | 0.69 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 212.85 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 213.05 | 4.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 213.06 | 1.37 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 213.07 | 4.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 213.1 | 1.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 213.12 | 0.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 213.15 | 6.03 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 213.58 | 5.04 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 213.58 | 7.19 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 214.06 | 0.56 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 214.07 | 5.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 214.08 | 4.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 214.84 | 0.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 215.02 | 0.78 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 215.06 | 0.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 215.13 | 6.04 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 216.06 | 3.69 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 217.03 | 3.26 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 217.04 | 4.18 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 217.1 | 2.2 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 217.1 | 4.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 217.11 | 1.34 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 217.12 | 0.85 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 217.12 | 4.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 217.13 | 0.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 217.15 | 0.7 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 218.02 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 218.04 | 1.29 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 218.12 | 4.38 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 218.14 | 0.9 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 218.14 | 4.71 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 218.19 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 218.94 | 0.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 219.12 | 4.05 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 219.17 | 0.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 219.17 | 5.76 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 220.12 | 1.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 220.14 | 5.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 220.17 | 0.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 220.91 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 220.94 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 221.05 | 0.73 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 221.09 | 0.91 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 221.09 | 1.36 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 221.16 | 0.76 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 221.18 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 222 | 2.21 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 222 | 3.32 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 222.9 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 223.03 | 3.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 223.07 | 5.13 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 223.08 | 1.56 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 223.1 | 7.17 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 223.13 | 5.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 224.03 | 2.46 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 224.09 | 1.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 225.02 | 0.51 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 225.06 | 3.09 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 225.06 | 4.13 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 225.06 | 4.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 225.07 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 225.07 | 4.11 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 225.08 | 5.13 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 225.11 | 3.99 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 225.11 | 4.98 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 226.02 | 0.54 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 226.07 | 1.51 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 227.06 | 4.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 227.11 | 7.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 227.12 | 0.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 227.12 | 1.87 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 227.12 | 2.89 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 227.12 | 4.52 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 227.13 | 5.28 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 227.13 | 5.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 228.02 | 1.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 229.12 | 1.54 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 229.14 | 3.4 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 229.14 | 6.33 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 229.15 | 0.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 229.15 | 3.18 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 229.15 | 5.09 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 229.15 | 5.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 229.15 | 5.9 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 230.18 | 1.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 231.04 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 231.08 | 1.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 231.12 | 3.08 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 231.14 | 6.69 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 231.15 | 0.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 231.16 | 5.12 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 232.02 | 1.05 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 232.02 | 4.13 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 232.03 | 3.88 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 232.12 | 3.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 232.15 | 1.33 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 233 | 7.04 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 233.08 | 4.91 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 233.11 | 0.87 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 235.13 | 6.37 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 235.17 | 5.79 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 235.18 | 3.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 236.06 | 3.2 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 236.18 | 3.96 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 236.88 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 237.09 | 6.05 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 237.11 | 4.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 237.12 | 1.3 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 237.18 | 6.51 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 237.98 | 3.73 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 238.1 | 4.22 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 238.88 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 239.08 | 4.3 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 239.09 | 3.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 239.09 | 7.17 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 239.1 | 0.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 239.13 | 4.73 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 239.23 | 0.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 240 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 240.03 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 240.07 | 5.3 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 240.18 | 4.18 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 240.99 | 0.54 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 241.02 | 1.11 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 241.08 | 4.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 241.09 | 0.98 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 241.1 | 4.05 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 241.15 | 0.83 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 241.22 | 0.78 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 242 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 242.1 | 5.13 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 243.12 | 3.88 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 243.13 | 3.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 244.06 | 0.92 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 244.15 | 2.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 244.96 | 0.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 245.08 | 0.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 245.14 | 3.76 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 245.14 | 5.35 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 245.15 | 0.87 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 246.17 | 3.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 246.95 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 247 | 0.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 247.06 | 0.89 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 247.06 | 5.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 247.1 | 4.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 247.11 | 2.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 247.13 | 1.44 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 247.14 | 2.15 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 247.14 | 5.21 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 247.2 | 0.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 248.09 | 2.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 248.1 | 1.17 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 248.14 | 0.97 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 248.17 | 6.69 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 249 | 0.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 249.01 | 2.44 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 249.07 | 1.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 249.11 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 250.06 | 7.27 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 250.07 | 1.69 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 250.1 | 1.23 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 250.15 | 6.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 251.02 | 2.21 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 251.03 | 3.88 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 251.11 | 0.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 251.13 | 5.28 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 251.13 | 7.28 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 251.13 | 8.17 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 252.97 | 0.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 253.11 | 6.47 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 253.14 | 5.32 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 253.98 | 1.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 254.08 | 4.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 254.14 | 5.04 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 254.83 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 255.03 | 0.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 255.13 | 1.28 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 255.16 | 6.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 256.01 | 0.62 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 256.99 | 1.9 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 257.06 | 4.09 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 257.08 | 4.05 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 257.1 | 4.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 257.15 | 4.12 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 257.15 | 4.43 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 257.16 | 0.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 257.16 | 7.26 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 257.23 | 7.41 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 258.02 | 0.88 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 258.17 | 3.43 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 259.04 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 259.07 | 4.39 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 259.09 | 0.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 259.09 | 4.39 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 259.11 | 2.09 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 259.16 | 4.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 259.2 | 0.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 260 | 1.48 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 260.15 | 0.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 260.19 | 3.89 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 260.2 | 1.56 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 260.93 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 261.05 | 0.62 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 261.09 | 4.4 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 261.11 | 4.39 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 261.13 | 2.04 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 261.13 | 3.95 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 261.14 | 1.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 262.16 | 0.9 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 262.16 | 5.36 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 262.91 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 262.92 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 263.07 | 3.83 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 263.1 | 3.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 263.1 | 4.4 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 263.12 | 5.31 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 263.13 | 5.31 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 263.14 | 3.34 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 263.14 | 4.33 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 263.17 | 0.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 264.03 | 0.9 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 264.04 | 0.9 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 264.14 | 7.8 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 264.16 | 5.36 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 264.97 | 0.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 265.07 | 5.15 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 265.08 | 0.62 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 265.09 | 3.91 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 265.11 | 3.92 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 265.11 | 5.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 265.12 | 4.96 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 265.14 | 5.3 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 266.04 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 266.1 | 3.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 266.1 | 4.34 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 267.06 | 0.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 267.1 | 8.16 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 267.12 | 2.87 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 267.12 | 7.33 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 267.12 | 8.16 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 267.13 | 2.87 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 267.13 | 3.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 268 | 3.31 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 268.02 | 1.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 268.04 | 0.54 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 268.09 | 4.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 268.11 | 0.69 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 268.11 | 0.81 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 269 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 269.12 | 0.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 269.14 | 4.39 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 269.14 | 4.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 269.23 | 7.36 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 269.97 | 1.34 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 270.13 | 5.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 270.83 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 271.08 | 0.85 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 271.09 | 0.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 271.17 | 5.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 271.2 | 7.56 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 271.21 | 6.26 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 271.99 | 1.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 272.13 | 6.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 272.17 | 6.73 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 272.19 | 4.17 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 272.19 | 4.7 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 273.07 | 4.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 273.17 | 5.05 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 273.22 | 7.46 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 273.62 | 7.47 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 274.02 | 2.85 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 274.02 | 7.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 274.18 | 7.33 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 274.19 | 4.85 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 274.2 | 4.97 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 275.04 | 1.29 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 275.11 | 1.88 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 275.11 | 3.46 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 275.19 | 7.31 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 276.12 | 7.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 276.14 | 3.79 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 276.15 | 5.68 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 276.18 | 1.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 276.18 | 7.31 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 276.2 | 7.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 276.9 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 277.08 | 4.37 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 277.1 | 4.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 277.14 | 5.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 278.04 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 278.07 | 4.48 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 278.1 | 4.37 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 278.14 | 3.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 278.87 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 278.88 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 278.9 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 278.95 | 0.56 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 279.04 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 279.1 | 5.47 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 279.12 | 5.3 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 279.13 | 1.18 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 279.13 | 3.51 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 279.14 | 0.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 280.12 | 3.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 281.04 | 1.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 281.09 | 3.29 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 281.11 | 1.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 281.11 | 1.79 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 281.11 | 3.43 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 281.12 | 6.23 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 281.15 | 5.15 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 281.62 | 6.25 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 282.01 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 282.11 | 4 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 282.11 | 5.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 282.12 | 0.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 283.05 | 4.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 283.09 | 5.35 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 283.11 | 0.9 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 283.11 | 4.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 283.12 | 4.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 283.12 | 5.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 283.13 | 4.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 283.14 | 0.69 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 283.15 | 0.68 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 283.15 | 5.13 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 283.17 | 3.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 284.04 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 284.06 | 1.38 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 284.09 | 2.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 284.19 | 4.5 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 284.97 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 285.09 | 2.96 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 285.12 | 3.95 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 285.13 | 3.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 285.26 | 7.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 286.04 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 286.11 | 0.96 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 286.12 | 0.96 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 286.2 | 5.3 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 286.97 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 287.04 | 0.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 287.06 | 0.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 287.09 | 4.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 287.1 | 2.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 287.1 | 3.4 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 287.2 | 5.31 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 288.03 | 4.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 288.2 | 6.23 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 288.22 | 5.68 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 288.22 | 6.23 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 289.12 | 4.49 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 289.14 | 3.2 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 289.16 | 4.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 289.19 | 0.69 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 290.1 | 5.87 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 290.14 | 5.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 290.16 | 1.03 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 291.12 | 5.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 291.12 | 5.98 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 292.16 | 3.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 292.88 | 0.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 293 | 1.79 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 293 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 293.04 | 2.39 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 293.06 | 0.83 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 293.1 | 6.47 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 293.12 | 5.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 294.01 | 2.42 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 294.02 | 1.33 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 294.03 | 3.35 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 294.1 | 6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 294.85 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 294.87 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 295.01 | 1.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 295.13 | 2.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 295.2 | 5.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 296 | 1.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 296.15 | 1.43 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 296.18 | 4.97 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 297.07 | 3.99 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 297.14 | 4.05 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 297.18 | 6.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 298.1 | 2.54 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 298.1 | 5.52 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 298.11 | 0.88 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 298.18 | 7.38 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 298.19 | 1.56 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 298.2 | 5.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 299.2 | 7.25 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 300.12 | 6.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 300.18 | 3.35 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 300.2 | 3.34 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 300.2 | 7.74 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 300.22 | 5.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 300.22 | 6.3 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 300.95 | 0.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 301.1 | 5.78 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 301.11 | 4.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 301.12 | 4.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 301.22 | 6.27 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 302.01 | 1.79 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 302.05 | 4.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 302.14 | 4.46 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 302.16 | 1.15 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 302.19 | 1.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 302.2 | 3.89 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 302.2 | 4.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 302.23 | 6.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 302.95 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 303.07 | 2.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 303.08 | 1 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 303.09 | 1 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 303.1 | 1.04 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 303.14 | 3.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 303.23 | 8.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 303.24 | 6.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 304.16 | 1.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 304.16 | 4.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 304.21 | 4.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 304.22 | 0.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 305.08 | 1.2 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 305.21 | 4.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 305.97 | 0.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 307.01 | 2.21 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 307.07 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 308.05 | 3.37 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 308.19 | 5.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 309 | 1.31 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 309.01 | 3.32 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 309.02 | 3.32 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 309.08 | 2.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 309.13 | 5.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 309.18 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 310.15 | 5.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 310.17 | 2.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 310.2 | 5.79 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 310.2 | 6.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 310.31 | 10.72 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 310.62 | 6.17 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 311.15 | 5.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 311.15 | 6.17 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 311.2 | 5.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 311.2 | 7.56 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 311.63 | 6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 312.13 | 1.21 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 312.14 | 6.03 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 312.22 | 5.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 312.22 | 6.26 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 312.22 | 6.81 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 313.13 | 1.2 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 313.21 | 7.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 313.22 | 5.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 314.23 | 6.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 314.23 | 6.99 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 314.99 | 0.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 315.13 | 5.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 315.15 | 5.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 315.24 | 6.99 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 316.07 | 4 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 316.2 | 7.15 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 316.25 | 7.35 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 316.92 | 0.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 317.03 | 0.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 318.11 | 3.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 318.13 | 0.62 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 318.19 | 3.23 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 318.21 | 6.16 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 318.92 | 0.58 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 319.14 | 3.12 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 319.16 | 3.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 319.19 | 5.31 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 319.19 | 7.2 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 319.23 | 7.88 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 321.06 | 0.87 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 322.04 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 322.99 | 0.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 326.01 | 2.21 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 326.15 | 0.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 326.2 | 6.37 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 326.96 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 327.07 | 1.2 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 327.17 | 7.39 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 327.18 | 6.38 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 327.2 | 3.65 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 328.2 | 4.08 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 328.21 | 5.11 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 328.21 | 5.47 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 328.25 | 7.48 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 329.01 | 0.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 329.19 | 5.11 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 330.19 | 3.62 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 330.23 | 4.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 330.23 | 5.3 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 330.23 | 5.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 330.23 | 6.56 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 331.01 | 0.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 331.23 | 5.67 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 332.19 | 6.01 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 332.21 | 3.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 332.24 | 4.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 332.24 | 5.43 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 332.24 | 6.34 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 334.02 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 336.22 | 6.39 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 336.32 | 10.1 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 336.33 | 10.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 337.03 | 1.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 337.04 | 1.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 337.18 | 3.77 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 338.07 | 2.45 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 338.13 | 5.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 338.18 | 7.18 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 340.21 | 5.28 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 340.25 | 7.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 341.07 | 1.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 341.11 | 3.23 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 341.17 | 3.28 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 341.25 | 7.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 342.17 | 7.02 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 342.23 | 4.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 342.24 | 4.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 342.25 | 7.91 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 342.26 | 7.93 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 342.93 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 343.06 | 0.82 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 343.12 | 3.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 343.22 | 5.12 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 344.21 | 4.34 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 344.23 | 3.66 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 344.24 | 4.91 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 344.24 | 6.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 344.25 | 5.1 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 344.9 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 345.14 | 5.27 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 345.15 | 5.27 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 346.21 | 4.69 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 346.22 | 3.27 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 346.22 | 4.69 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 346.26 | 6.87 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 347.17 | 5.04 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 347.22 | 6.17 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 347.23 | 6.8 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 348.07 | 1.27 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 348.33 | 8.43 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 349.24 | 5.62 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 350.11 | 3.46 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 350.16 | 5.03 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 350.23 | 7.12 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 351 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 351.18 | 6.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 352.03 | 2.46 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 352.17 | 7.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 353.02 | 2.44 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 354.07 | 1.17 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 354.08 | 1.14 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 354.78 | 0.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 355.12 | 4.13 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 355.17 | 7.06 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 356.03 | 1.61 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 356.07 | 3.21 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 356.24 | 7 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 356.28 | 8.23 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 357.25 | 6.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 358.08 | 3.75 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 358.21 | 3.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 358.21 | 4.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 358.22 | 4.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 358.26 | 6.29 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 358.26 | 7.26 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 358.3 | 8.43 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 358.9 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 359.26 | 7.25 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 360.88 | 0.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 360.96 | 0.56 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 363.09 | 2.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 363.16 | 3.55 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 363.16 | 3.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 363.21 | 5.76 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 364.2 | 5.04 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 365.1 | 0.7 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 365.23 | 6.17 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 366.37 | 11.16 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 366.98 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 367.06 | 1.16 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 367.15 | 0.91 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 368.28 | 8.19 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 368.98 | 0.57 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 369.02 | 1.27 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 369.39 | 9.59 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 370.18 | 5.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 370.26 | 6.26 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 371.17 | 5.12 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 372.21 | 4.95 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 372.24 | 4.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 372.24 | 5.64 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 372.27 | 6.63 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 372.35 | 9.42 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 373.15 | 3.47 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 373.17 | 6.53 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 373.27 | 7.16 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 374.25 | 5.94 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 376.01 | 2.46 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 376.85 | 0.6 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 377.14 | 3.56 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 377.18 | 7.07 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 378.05 | 2.86 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 378.18 | 2.84 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 379.21 | 5.24 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 380.23 | 7.23 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000616 | 382.08 | 3.44 | Minutes | ST000382 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
